Industry: Pharmaceuticals, Biotechnology
CAT is a UK-based biotechnology company using its proprietary technologies and capabilities in human monoclonal antibodies for drug discovery and drug development. Based near Cambridge, England, CAT currently employs around 290 people. CAT is a leader in the discovery and development of human therapeutic antibodies and has an advanced proprietary platform technology for rapidly isolating human monoclonal antibodies using phage display systems. CAT has extensive phage antibody libraries, currently incorporating more than 100 billion distinct antibodies. These libraries form the basis for the Company’s strategy to develop a portfolio of antibody-based ( www.cambridgeantibody.com )
Cambridge Antibody Technology Limited
The Science Park
Melbourn, Cambridgeshire SG8 6JJ
United Kingdom
Tel: +44 1763 263 233
Fax: +44 1763 263 413